“Maximum”的搜索结果，显示 121-130 项，共有 2443 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 dose (RP2D) and schedule of KTX-1001 ...